Real-time enrollment status for this gastroparesis clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 8:49 AM UTC
| NCT Number | NCT05621811 |
| Recruiting Status | Recruiting |
| Condition | Gastroparesis |
| Phase | Clinical Trial |
| Target Enrollment | 320 participants |
| Active Locations | 21 sites in the US |
| Sponsor | Dr. Falk Pharma GmbH |
| Last Updated on CT.gov | February 6, 2025 (Feb 6, 2025) |
As of March 2, 2026: Clinical trial NCT05621811 is currently recruiting participants. This clinical trial study for gastroparesis is actively seeking new participants at 21 locations across the United States. The study is sponsored by Dr. Falk Pharma GmbH. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05621811 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 21 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05621811 was last updated Feb 6, 2025 (February 6, 2025). HelloStudys verifies this status automatically.